The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review.

MLA

Cramer JA, et al. “The Significance of Compliance and Persistence in the Treatment of Diabetes, Hypertension and Dyslipidaemia: A Review.” International Journal of Clinical Practice, vol. 62, no. 1, Jan. 2008, pp. 76–87. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=105722015&authtype=sso&custid=ns315887.

APA

Cramer JA, Benedict A, Muszbek N, Keskinaslan A, Khan ZM, Cramer, J. A., Benedict, A., Muszbek, N., Keskinaslan, A., & Khan, Z. M. (2008). The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review. International Journal of Clinical Practice, 62(1), 76–87.

Chicago

Cramer JA, Benedict A, Muszbek N, Keskinaslan A, Khan ZM, J A Cramer, A Benedict, N Muszbek, A Keskinaslan, and Z M Khan. 2008. “The Significance of Compliance and Persistence in the Treatment of Diabetes, Hypertension and Dyslipidaemia: A Review.” International Journal of Clinical Practice 62 (1): 76–87. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=105722015&authtype=sso&custid=ns315887.